Treating acquired haemophilia: an ethical conundrum.
Starr
J M
JM
D000284:Administration, Oral; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003006:Clopenthixol / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives; D004739:England; D004992:Ethics, Medical; D005260:Female; D006467:Hemophilia A / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D007273:Injections, Intramuscular; D016743:Mental Competency / Q000331:legislation & jurisprudence; D010259:Paranoid Disorders / Q000097:blood / Q000188:drug therapy*; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects; D016312:Treatment Refusal / Q000331:legislation & jurisprudence*
D014150:Antipsychotic Agents; C060342:clopenthixol acetate ester; D003006:Clopenthixol; D018967:Risperidone